Full text
PDF








Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- COURTOIS G., FLACK A., JERVIS G. A., KOPROWSKI H., NINANE G. Preliminary report on mass vaccination of man with live attenuated poliomyelitis virus in the Belgian Congo and Ruanda-Urundi. Br Med J. 1958 Jul 26;2(5090):187–190. doi: 10.1136/bmj.2.5090.187. [DOI] [PMC free article] [PubMed] [Google Scholar]
- DICK G. W., DANE D. S. Vaccination against poliomyelitis with live virus vaccines. 4. A review of the present position. Br Med J. 1958 Nov 15;2(5106):1184–1186. doi: 10.1136/bmj.2.5106.1184. [DOI] [PMC free article] [PubMed] [Google Scholar]
- GELFAND H. M., POTASH L., LEBLANC D. R., FOX J. P. Intrafamilial and interfamilial spread of living vaccine strains of polioviruses. J Am Med Assoc. 1959 Aug 22;170(17):2039–2048. doi: 10.1001/jama.1959.03010170001001. [DOI] [PubMed] [Google Scholar]
- HORSTMANN D. M., NIEDERMAN J. C., MELNICK J. L., PAUL J. R. Poliomyelitis: comparison of responses of vaccinated and naturally immune humans to ingestion of attenuated poliovirus. Trans Assoc Am Physicians. 1957;70:91–101. [PubMed] [Google Scholar]
- HORSTMANN D. M., NIEDERMAN J. C., PAUL J. R. Attenuated type 1 poliovirus vaccine; its capacity to infect and to spread from vaccinees within an institutional population. J Am Med Assoc. 1959 May 2;170(1):1–8. doi: 10.1001/jama.1959.03010010003001. [DOI] [PubMed] [Google Scholar]
- HORSTMANN D. M., NIEDERMAN J. C., RIORDAN J. T., PAUL J. R. The trial use of Sabin's attenuated type 1 poliovirus vaccine in a village in southern Arizina. Am J Hyg. 1959 Sep;70:169–184. doi: 10.1093/oxfordjournals.aje.a120068. [DOI] [PubMed] [Google Scholar]
- KOPROWSKI H., JERVIS G. A., NORTON T. W. Immune responses in human volunteers upon oral administration of a rodent-adapted strain of poliomyelitis virus. Am J Hyg. 1952 Jan;55(1):108–124. doi: 10.1093/oxfordjournals.aje.a119499. [DOI] [PubMed] [Google Scholar]
- PAUL J. R. Properties of an ideal poliomyelitis vaccine. Bull N Y Acad Med. 1956 Oct;32(10):747–752. [PMC free article] [PubMed] [Google Scholar]
- PLOTKIN S. A., KOPROWSKI H., STOKES J., Jr Clinical trials in infants of orally administered attenuated poliomyelitis viruses. Pediatrics. 1959 Jun;23(6):1041–1062. [PubMed] [Google Scholar]
- SABIN A. B. Characteristics and genetic potentialities of experimentally produced and naturally occurring variants of poliomyelitis virus. Ann N Y Acad Sci. 1955 Sep 27;61(4):924-38; discussion, 938-9. doi: 10.1111/j.1749-6632.1955.tb42551.x. [DOI] [PubMed] [Google Scholar]
- SALK J. E. Vaccination against poliomyelitis: an ounce of prevention. R Soc Health J. 1959 Jul-Aug;79:310–322. doi: 10.1177/146642405907900405. [DOI] [PubMed] [Google Scholar]
- VERLINDE J. D., WILTERDINK J. B., KRET A. Active immunization against poliomyelitis with live attenuated viruses. Arch Gesamte Virusforsch. 1959;8(5):549–564. doi: 10.1007/BF01242240. [DOI] [PubMed] [Google Scholar]